Abstract
Background
Two-stage exchange arthroplasty is a feasible treatment for chronic PJI (periprosthetic joint infection) of total hip arthroplasty (THA). However, there are large numbers of patients who are unable to ultimately receive reimplantation after resection arthroplasty owing to uncontrolled infection and multiple comorbidities. The purpose of the current study was to identify patient-related risk factors and reasons for being unable to undergo revision THA.
Methods
Individuals undergoing resection arthroplasty for chronic PJI treatment from 2013 to 2020 at our institution were retrospectively reviewed. A variety of patient comorbidities, laboratory data, isolated pathogens, and follow-up status were collected for analysis.
Results
A total of 84 patients (46 men and 38 women) with a 2.7 ± 2.1-year follow-up were analyzed. Thirty-eight (45.2%) patients eventually underwent revision THA, while the other 46 (54.8%) did not receive reimplantation during follow-up. The patients without receiving reimplantation had higher Charlson comorbidity index (CCI) score (3.1 ± 2.9 versus 1.2 ± 1.5; p = 0.001). Lower cumulative incidence of receiving reimplantation was observed in patients with chronic kidney disease (log-rank test, p = 0.019), anemia (p = 0.011), presence of initial fever (p = 0.030), and oxacillin-resistant strain infection (p = 0.030). The most common reasons for not receiving reimplantation were uncontrolled infection, unstable medical conditions, and death. The patients without reimplantation had a relatively higher mortality rate (log-rank test, p = 0.002).
Conclusion
Chronic hip PJI with poor medical conditions or oxacillin-resistant strain infection decreased the chance of undergoing revision surgery. These patients had unfavourable outcomes and a higher mortality rate after resection arthroplasty.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00264-021-05254-4/MediaObjects/264_2021_5254_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00264-021-05254-4/MediaObjects/264_2021_5254_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00264-021-05254-4/MediaObjects/264_2021_5254_Fig3_HTML.png)
Similar content being viewed by others
Data Availability
All data generated or analyzed during this study are included in this published article.
Change history
19 January 2022
A Correction to this paper has been published: https://doi.org/10.1007/s00264-021-05297-7
References
Singh JA (2011) Epidemiology of knee and hip arthroplasty: a systematic review. Open Orthop J 5:80
Pivec R, Johnson AJ, Mears SC, Mont MA (2012) Hip arthroplasty. Lancet 380(9855):1768–1777
Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89(4):780–785. https://doi.org/10.2106/JBJS.F.00222
Kumar A, Tsai WC, Tan TS, Kung PT, Chiu LT, Ku MC (2015) Temporal trends in primary and revision total knee and hip replacement in Taiwan. J Chin Med Assoc 78(9):538–544. https://doi.org/10.1016/j.jcma.2015.06.005
Hunt LP, Ben-Shlomo Y, Clark EM, Dieppe P, Judge A, MacGregor AJ, Tobias JH, Vernon K, Blom AW (2013) 90-day mortality after 409 096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis. Lancet 382(9898):1097–1104. https://doi.org/10.1016/s0140-6736(13)61749-3
Ulrich SD, Seyler TM, Bennett D, Delanois RE, Saleh KJ, Thongtrangan I, Kuskowski M, Cheng EY, Sharkey PF, Parvizi J (2008) Total hip arthroplasties: what are the reasons for revision? Int Orthop 32(5):597–604
Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J (2009) Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 24(6):105–109
Chang CH, Lee SH, Lin YC, Wang YC, Chang CJ, Hsieh PH (2020) Increased periprosthetic hip and knee infection projected from 2014 to 2035 in Taiwan. J Infect Public Health 13(11):1768–1773. https://doi.org/10.1016/j.jiph.2020.04.014
Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J (2012) Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 27(8):61-65.e61. https://doi.org/10.1016/j.arth.2012.02.022
Kim TW, Kang SB, Chang CB, Moon SY, Lee YK, Koo KH (2021) Current trends and projected burden of primary and revision total knee arthroplasty in korea between 2010 and 2030. J Arthroplasty 36(1):93–101. https://doi.org/10.1016/j.arth.2020.06.064
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR (2012) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis 56(1):e1–e25. https://doi.org/10.1093/cid/cis803
Biring G, Kostamo T, Garbuz D, Masri B, Duncan C (2009) Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10-to 15-year follow-up study. J Bone Joint Surg British 91(11):1431–1437
Chen SY, Hu CC, Chen CC, Chang YH, Hsieh PH (2015) Two-stage revision arthroplasty for periprosthetic hip infection: mean follow-up of ten years. Biomed Res Int 2015:345475. https://doi.org/10.1155/2015/345475
Sanchez-Sotelo J, Berry DJ, Hanssen AD, Cabanela ME (2009) Midterm to long-term followup of staged reimplantation for infected hip arthroplasty. Clin Orthop Relat Res 467(1):219–224
Triantafyllopoulos GK, Memtsoudis SG, Zhang W, Ma Y, Sculco TP, Poultsides LA (2017) Periprosthetic infection recurrence after 2-stage exchange arthroplasty: failure or fate? J Arthroplasty 32(2):526–531. https://doi.org/10.1016/j.arth.2016.08.002
Sia IG, Berbari EF, Karchmer AW (2005) Prosthetic joint infections. Infect Dis Clin 19(4):885–914
Laor A, Tal S, Guller V, Zbar AP, Mavor E (2016) The Charlson comorbidity index (CCI) as a mortality predictor after surgery in elderly patients. Am Surg 82(1):22–27
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383. https://doi.org/10.1016/0021-9681(87)90171-8
Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, Chen AF, Shohat N (2018) The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty 33(5):1309-1314.e1302. https://doi.org/10.1016/j.arth.2018.02.078
Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG (2011) New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res® 469(11):2992–2994
Cancienne JM, Werner BC, Bolarinwa SA, Browne JA (2017) Removal of an infected total hip arthroplasty: risk factors for repeat debridement, long-term spacer retention, and mortality. J Arthroplasty 32(8):2519–2522. https://doi.org/10.1016/j.arth.2017.03.018
Spiegl U, Friederichs J, Pätzold R, Militz M, Josten C, Bühren V (2013) Risk factors for failed two-stage procedure after chronic posttraumatic periprosthetic hip infections. Arch Orthop Trauma Surg 133(3):421–428
Tornero E, Senneville E, Euba G, Petersdorf S, Rodriguez-Pardo D, Lakatos B, Ferrari MC, Pilares M, Bahamonde A, Trebse R, Benito N, Sorli L, del Toro MD, Baraiaetxaburu JM, Ramos A, Riera M, Jover-Saenz A, Palomino J, Ariza J, Soriano A, European Society Group of Infections on Artificial I (2014) Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study. Clin Microbiol Infect 20(11):1219–1224. https://doi.org/10.1111/1469-0691.12721
Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, Berry DJ (2012) Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. JBJS 94(9):794–800
Lu M, Sing DC, Kuo AC, Hansen EN (2017) Preoperative anemia independently predicts 30-day complications after aseptic and septic revision total joint arthroplasty. J Arthroplasty 32(9):S197–S201
Pedersen AB, Svendsson JE, Johnsen SP, Riis A, Overgaard S (2010) Risk factors for revision due to infection after primary total hip arthroplasty: a population-based study of 80,756 primary procedures in the Danish Hip Arthroplasty Registry. Acta Orthop 81(5):542–547
Tan TL, Kheir MM, Tan DD, Filippone EJ, Tischler EH, Chen AF (2016) Chronic kidney disease linearly predicts outcomes after elective total joint arthroplasty. J Arthroplast 31(9):175-179.e172
Jhan SW, Lu YD, Lee MS, Lee CH, Wang JW, Kuo FC (2017) The risk factors of failed reimplantation arthroplasty for periprosthetic hip infection. BMC Musculoskelet Disord 18(1):255. https://doi.org/10.1186/s12891-017-1622-1
Kandel CE, Jenkinson R, Daneman N, Backstein D, Hansen BE, Muller MP, Katz KC, Widdifield J, Bogoch E, Ward S, Sajja A, Jeldes FG, McGeer A (2019) Predictors of treatment failure for hip and knee prosthetic joint infections in the setting of 1- and 2-stage exchange arthroplasty: a multicenter retrospective cohort. Open Forum Infect Dis 6(11):ofz452. https://doi.org/10.1093/ofid/ofz452
Houdek MT, Wagner ER, Watts CD, Osmon DR, Hanssen AD, Lewallen DG, Mabry TM (2015) Morbid obesity: a significant risk factor for failure of two-stage revision total hip arthroplasty for infection. J Bone Joint Surg Am 97(4):326–332. https://doi.org/10.2106/JBJS.N.00515
Wouthuyzen-Bakker M, Sebillotte M, Lomas J, Taylor A, Palomares EB, Murillo O, Parvizi J, Shohat N, Reinoso JC, Sánchez RE, Fernandez-Sampedro M, Senneville E, Huotari K, Barbero JM, Garcia-Cañete J, Lora-Tamayo J, Ferrari MC, Vaznaisiene D, Yusuf E, Aboltins C, Trebse R, Salles MJ, Benito N, Vila A, Toro MDD, Kramer TS, Petersdorf S, Diaz-Brito V, Tufan ZK, Sanchez M, Arvieux C, Soriano A (2019) Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention. J Infect 78(1):40–47. https://doi.org/10.1016/j.**f.2018.07.014
Paharik AE, Horswill AR (2016) The staphylococcal biofilm: adhesins, regulation, and host response. Microbiol Spectr 4 (2). https://doi.org/10.1128/microbiolspec.VMBF-0022-2015
Gao Z, Du Y, Piao S, Sun J, Li X, Zhou Y (2019) Comparison between the Staphylococci aureus and coagulase-negative staphylococci infected total joint arthroplasty treated by two-stage revision: a retrospective study with two year minimum follow-up. J Orthop Sci 24(1):109–115. https://doi.org/10.1016/j.jos.2018.04.017
Kilgus DJ, Howe DJ, Strang A (2002) Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res® 404:116–124
Bozhkova S, Tikhilov R, Labutin D, Denisov A, Shubnyakov I, Razorenov V, Artyukh V, Rukina A (2016) Failure of the first step of two-stage revision due to polymicrobial prosthetic joint infection of the hip. J Orthop Traumatol 17(4):369–376
Gao Z, Li X, Du Y, Peng Y, Wu W, Zhou Y (2018) Success rate of fungal peri-prosthetic joint infection treated by 2-stage revision and potential risk factors of treatment failure: a retrospective study. Med Sci Monit 24:5549–5557. https://doi.org/10.12659/msm.909168
Acknowledgements
This work was partially supported by a research grant from National Cheng Kung University Hospital.
Funding
This work was partially supported by a research grant from our hospital. No external funding was received to assist with the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
TWT contributes to conceptualization and methodology. YHL and CJC perform formal analysis and investigation. YHL was a major contributor in writing the manuscript. Writing — review and editing — was done by CWC and TWT. TWT and CYC contribute to revision. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original version of this article was revised. The correct copyright should be "The Author(s) under exclusive licence to SICOT aisbl."
Rights and permissions
About this article
Cite this article
Lin, YH., Chang, CJ., Chang, CW. et al. The reasons for and mortality of patients unable to receive reimplantation after resection arthroplasty for chronic hip periprosthetic infection. International Orthopaedics (SICOT) 46, 465–472 (2022). https://doi.org/10.1007/s00264-021-05254-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-021-05254-4